Visceral Adiposity and Cardiometabolic Health Interventions

Visceral adiposity refers to the accumulation of fat within the abdominal cavity, surrounding internal organs, and is a recognised driver of cardiometabolic dysfunction. Unlike subcutaneous fat, visceral fat exhibits heightened lipolytic activity and secretes pro-inflammatory adipokines that impair insulin sensitivity, elevate blood pressure and dysregulate lipid profiles. Research over the past decade has elucidated the mechanistic links between visceral adipose tissue and the pathogenesis of metabolic syndrome, type 2 diabetes and cardiovascular disease. Interventions targeting visceral fat reduction span lifestyle modification, pharmacotherapy and emerging device-based approaches. Dietary strategies emphasise macronutrient composition and caloric restriction, while structured exercise regimens exploit enhanced fatty acid oxidation in visceral depots. Pharmacological agents such as glucagon-like peptide 1 receptor agonists have demonstrated selective reductions in visceral adiposity alongside improvements in glycaemic control. Novel imaging and biochemical indices now permit earlier detection of visceral adipose dysfunction, enabling personalised intervention and dynamic monitoring of treatment response. Collectively, these advances underscore the global imperative to integrate precise assessment of visceral fat into cardiometabolic risk stratification and to refine interventions that specifically attenuate visceral adiposity.

Research from Nature Portfolio

Recent investigations have refined quantitative measures of visceral fat and demonstrated their prognostic value for metabolic outcomes. A longitudinal cohort study of nearly 2 000 apparently healthy adults employed serial imaging to show that increases in visceral adipose tissue area were robustly associated with incident metabolic syndrome over five years, whereas expansion of subcutaneous depots correlated inversely with risk factors such as elevated blood pressure and dysglycaemia. Separately, a novel composite index integrating age, anthropometry and routine lipid parameters was developed and validated for the prediction of type 2 diabetes and pre-diabetes. This index outperformed traditional measures—including body mass index and waist circumference—by achieving higher discrimination of future dysglycaemia in community-based populations. These findings establish precise phenotyping of visceral adiposity as a keystone for early identification of individuals at high cardiometabolic risk and for tailoring preventive strategies.

Visceral Adiposity and Cardiometabolic Health Interventions publication trend

The graph below shows the total number of articles in visceral adiposity and cardiometabolic health interventions across all publications each year (not limited to Nature Index journals).

Technical terms

Visceral adiposity: Fat accumulation within the abdominal cavity surrounding internal organs, strongly linked to cardiometabolic risk.

Metabolic syndrome: A cluster of conditions—including insulin resistance, hypertension, dyslipidaemia and central obesity—that increase cardiovascular morbidity and mortality.

Visceral adiposity index (VAI): A mathematical model combining waist circumference, body mass index, triglycerides and HDL cholesterol to estimate visceral fat dysfunction.

Chinese visceral adiposity index (CVAI): A population-specific index calibrated for Chinese adults that integrates age, anthropometric measures and lipid parameters to assess visceral fat and predict metabolic outcomes.

Hounsfield unit: A quantitative scale for describing radiodensity in computed tomography, used to characterise tissue composition and inflammation in adipose depots.

References

1. High visceral fat attenuation and long‐term mortality in a health check‐up population. Journal of Cachexia Sarcopenia and Muscle (2023).
2. Association between diagnostic imaging and biochemical markers: a possible tool for monitoring metabolic disorders. Current Opinion in Food Science (2024).
3. Association between Chinese visceral adiposity index and risk of stroke incidence in middle-aged and elderly Chinese population: evidence from a large national cohort study. Journal of Translational Medicine (2023).
4. Body Fat Distribution and the Risk of Incident Metabolic Syndrome: A Longitudinal Cohort Study. Scientific Reports (2017).
5. A Novel Visceral Adiposity Index for Prediction of Type 2 Diabetes and Pre-diabetes in Chinese adults: A 5-year prospective study. Scientific Reports (2017).